Cargando…
Personalized medicine enrichment design for DHA supplementation clinical trial
Personalized medicine aims to match patient subpopulation to the most beneficial treatment. The purpose of this study is to design a prospective clinical trial in which we hope to achieve the highest level of confirmation in identifying and making treatment recommendations for subgroups, when the ri...
Autores principales: | Lei, Yang, Mayo, Matthew S., Carlson, Susan E., Gajewski, Byron J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5308793/ https://www.ncbi.nlm.nih.gov/pubmed/28217765 http://dx.doi.org/10.1016/j.conctc.2017.01.002 |
Ejemplares similares
-
Subgroup identification of early preterm birth (ePTB): informing a future prospective enrichment clinical trial design
por: Zhang, Chuanwu, et al.
Publicado: (2017) -
Higher-Dose DHA Supplementation Modulates Immune Responses in Pregnancy and Is Associated with Decreased Preterm Birth
por: Valentine, Christina J., et al.
Publicado: (2021) -
Assessment of DHA on reducing early preterm birth: the ADORE randomized controlled trial protocol
por: Carlson, Susan E., et al.
Publicado: (2017) -
Prenatal docosahexaenoic acid effect on maternal-infant DHA-equilibrium and fetal neurodevelopment: a randomized clinical trial
por: Gustafson, Kathleen M., et al.
Publicado: (2021) -
Randomized Controlled Trial of DHA Supplementation during Pregnancy: Child Adiposity Outcomes
por: Foster, Byron A., et al.
Publicado: (2017)